Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
48.77
+0.83 (+1.73%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,248,361
Open
49.02
Bid (Size)
48.55 (100)
Ask (Size)
48.90 (10,000)
Prev. Close
47.94
Today's Range
48.61 - 49.55
52wk Range
35.12 - 71.80
Shares Outstanding
N/A
Dividend Yield
5.23%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Top Growth Stocks to Buy Right Now Without Hesitation
↗
June 29, 2026
These stocks are no-brainer buys.
Via
The Motley Fool
Topics
Economy
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
↗
June 29, 2026
These stocks are better bets to skyrocket than the much-hyped rocket stock.
Via
The Motley Fool
Performance
YTD
-6.9%
-6.9%
1 Month
+10.7%
+10.7%
3 Month
+33.7%
+33.7%
6 Month
-4.1%
-4.1%
1 Year
-30.1%
-30.1%
More News
Read More
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
↗
June 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly?
↗
June 26, 2026
Via
The Motley Fool
An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?
↗
June 25, 2026
Via
The Motley Fool
The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch
↗
June 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
2 Underrated Weight Loss Stocks to Buy and Hold
↗
June 23, 2026
Via
The Motley Fool
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
↗
June 22, 2026
Via
The Motley Fool
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?
↗
June 20, 2026
Via
The Motley Fool
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
↗
June 20, 2026
Via
MarketBeat
Topics
ETFs
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
↗
June 16, 2026
Via
The Motley Fool
3 Under-the-Radar Stocks to Buy and Hold for a Decade
↗
June 16, 2026
Via
The Motley Fool
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
↗
June 14, 2026
Via
The Motley Fool
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About
↗
June 12, 2026
Via
The Motley Fool
Is Viking Therapeutics Stock Going to $100?
↗
June 12, 2026
Via
The Motley Fool
Why Pfizer Stock Popped Today
↗
June 11, 2026
Via
The Motley Fool
80% of Wegovy Pill Users Never Took a Weight Loss Drug Before. Does This Number Change the Entire Novo Nordisk Bear Case?
↗
June 07, 2026
Via
The Motley Fool
Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?
↗
June 06, 2026
Via
The Motley Fool
Topics
Intellectual Property
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors
↗
June 05, 2026
Via
The Motley Fool
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
↗
June 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better
↗
June 03, 2026
Via
The Motley Fool
Here's What I Think Is Really Going on With Novo Nordisk Stock
↗
June 03, 2026
Via
The Motley Fool
Bull vs. Bear: The Quick Take on Viking Therapeutics Stock
↗
June 03, 2026
Via
The Motley Fool
Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage
↗
June 02, 2026
Via
MarketBeat
Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down
↗
June 02, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.77
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 07/01/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today